Player FM - Internet Radio Done Right
Checked 12h ago
three 年前 前追加した
コンテンツは Targeted Talks によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Targeted Talks またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!
Player FMアプリでオフラインにしPlayer FMう!
聞く価値のあるポッドキャスト
スポンサード
“If we march into that village and we start trying to persecute people for using poison, something that's very illegal, nobody's going to talk to us. We're not going to find out where the poison came from. We're not going to be able to shut anything down. We should take the approach that people are using poison because they're desperate, because they see no other alternative.” – Andrew Stein Andrew Stein is a wildlife ecologist who spent the past 25 years studying human carnivore conflict from African wild dogs and lions in Kenya and Botswana to leopards and hyenas in Namibia. His work has long focused on finding ways for people and predators to coexist. He is the founder of CLAWS , an organization based in Botswana that's working at the intersection of cutting-edge wildlife research and community driven conservation. Since its start in 2014 and official launch as an NGO in 2020, CLAWS has been pioneering science-based, tech-forward strategies to reduce conflict between people and carnivores. By collaborating closely with local communities, especially traditional cattle herders, CLAWS supports both species conservation and rural livelihoods—making coexistence not just possible, but sustainable.…
Targeted Talks
すべての項目を再生済み/未再生としてマークする
Manage series 3293365
コンテンツは Targeted Talks によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Targeted Talks またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Targeted Oncology brings you Targeted Talks, a monthly podcast featuring discussions with academic and community oncologists surrounding advancements in cancer research and best practices for patient management.
…
continue reading
71 つのエピソード
すべての項目を再生済み/未再生としてマークする
Manage series 3293365
コンテンツは Targeted Talks によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Targeted Talks またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Targeted Oncology brings you Targeted Talks, a monthly podcast featuring discussions with academic and community oncologists surrounding advancements in cancer research and best practices for patient management.
…
continue reading
71 つのエピソード
Όλα τα επεισόδια
×T
Targeted Talks

1 S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning 36:35
36:35
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った36:35
In this episode of Emerging Experts, Xiaojie Zhang, MD, a hematology/oncology fellow, and Akshat Singhal, PhD, a postdoctoral scholar, both at UC San Diego, shed light on innovative research leveraging deep learning to predict how patients with ER-positive/HER2-negative (ER+/HER2-) breast cancer will respond to palbociclib (Ibrance), a common first-line treatment for this patient population. Their work, fueled by the desire to improve precision oncology, demonstrates the significant potential of artificial intelligence (AI) in guiding cancer care.…
T
Targeted Talks

1 S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall 14:48
14:48
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った14:48
In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.…
T
Targeted Talks

1 S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain 27:50
27:50
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った27:50
David A. Russler-Germain, MD, PhD, physician-scientist at Washington University School of Medicine and Siteman Cancer Center, discusses his path in oncology and the many advancements shaping lymphoma treatment today.
T
Targeted Talks

1 S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia 8:13
8:13
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った8:13
In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan for the treatment of patients with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have received prior systemic therapy.
T
Targeted Talks

1 S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment 35:13
35:13
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った35:13
In this episode of Targeted Talks, Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses the exciting advancements of artificial intelligence in 2024, specifically focusing on its transformative impact on early cancer detection.
T
Targeted Talks

1 S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research 16:28
16:28
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った16:28
In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the transformative impact of artificial intelligence in oncology.
T
Targeted Talks

1 S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander 27:56
27:56
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った27:56
In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.…
T
Targeted Talks

1 S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology 16:20
16:20
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った16:20
Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing research.
T
Targeted Talks

1 S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer 13:41
13:41
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った13:41
In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the phase 3 EMERALD trial.…
T
Targeted Talks

In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm.
T
Targeted Talks

1 S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates 30:43
30:43
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った30:43
In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.…
T
Targeted Talks

1 S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel 16:05
16:05
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った16:05
In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.
T
Targeted Talks

1 S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US 19:23
19:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った19:23
In this episode of Emerging Experts, Yu Fujiwara, shares his journey from Japan to the United States and his path to becoming a specialist in hematology and oncology.
T
Targeted Talks

1 S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role 18:04
18:04
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った18:04
In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.
T
Targeted Talks

1 S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine 23:58
23:58
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った23:58
Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.
プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。